RNU6-1095P

Across TCGA pan-cancer cohorts, RNU6-1095P RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated RNU6-1095P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-1095P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU6-1095P expression acts as an unfavorable survival marker, although some lineages such as BLCA and ACC show a favorable association.

BLCA, ACC, and UCS are the cancer types where RNU6-1095P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.583	0.326	<.001	52	view →
ACC	OS	Median	IV	0.917	0.517	.006	38	view →
UCS	DFS	Median	IV	0.952	0.367	.001	36	view →
UVM	DFS	Tertile	III,IV	0.267	0.927	.001	32	view →
THCA	DFS	Quartile	II,III,IV	0.887	0.950	.009	26	view →
UCEC	DFS	Quartile	All	0.583	0.820	.001	24	view →
ESCA	DFS	Median	III,IV	0.423	0.225	.014	18	view →
KICH	DFS	Median	III,IV	1.000	0.373	.009	15	view →
KIRP	DFS	Quartile	IV	0.556	0.864	.010	14	view →
PRAD	DFS	Quartile	All	0.874	0.950	.020	12	view →
CHOL	DFS	Tertile	III,IV	0.163	0.779	.024	9	view →
LUAD	OS	Tertile	II,III,IV	0.714	0.521	.021	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

RNU6-1095P–BLCA (OS)

Open the BLCA breakdown →